Company profile for Provention Bio

Sanofi-PSE
News

DATA COMPILATION
#PharmaFlow

PharmaCompass
Related CompaniesRelated Companies

About

Provention Bio is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated diseases. At Provention Bio, they approach autoimmune disease differently than traditional pharma, with a clear focus on early interception. Their lead investigational product candidate is currently under review by the U.S. FDA for the delay or prevention of clinical type 1 diabetes in at-risk individuals. The pipeline includes additional clinical-stage product candidates for autoimmune diseases, including celiac disease and lupus.

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
55 Broad Street, 2nd Floor Red Bank, NJ 07701
Telephone
Telephone
+1 908.336.0360
youtube
YouTube
Twitter
Twitter
Contact Info
Others

Events

Webinars & Exhibitions

A PHP Error was encountered

Severity: Warning

Message: Undefined variable $tile1

Filename: tabs/exhibitions.php

Line Number: 43

Backtrace:

File: /var/www/html/application/views/include/party/inc/tabs/exhibitions.php
Line: 43
Function: _error_handler

File: /var/www/html/application/models/CmnPec.php
Line: 1625
Function: view

File: /var/www/html/application/views/include/party/query.php
Line: 575
Function: create

File: /var/www/html/application/views/include/party/indexNew.php
Line: 70
Function: include

File: /var/www/html/application/views/commonNew.php
Line: 445
Function: include

File: /var/www/html/application/controllers/PharmaServices.php
Line: 4651
Function: view

File: /var/www/html/index.php
Line: 224
Function: require_once

Default Event

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content read-more

Explore the latest content creation from this company

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2023/04/26/2654655/0/en/Press-Release-Hart-Scott-Rodino-waiting-period-expires-for-Sanofi-s-acquisition-of-Provention-Bio-Inc.html

GLOBENEWSWIRE
26 Apr 2023
Sanofi's Provention buy hit with FTC delay
Sanofi's Provention buy hit with FTC delay

11 Apr 2023

// Angus Liu FIERCE PHARMA

https://www.fiercepharma.com/pharma/sanofis-29b-deal-provention-bio-hit-protracted-ftc-review-wheres-pfizer-seagen

Angus Liu FIERCE PHARMA
11 Apr 2023

https://www.sanofi.com/en/media-room/press-releases/2023/2023-03-13-06-00-00-2625367

PRESS RELEASE
14 Mar 2023

https://www.prnewswire.com/news-releases/provention-bio-cancels-fourth-quarter-and-full-year-2022-earnings-release-and-conference-call-301769842.html

PR NEWSWIRE
13 Mar 2023

https://www.prnewswire.com/news-releases/provention-bio-announces-the-grant-of-inducement-awards-301761851.html

PR NEWSWIRE
03 Mar 2023

https://www.prnewswire.com/news-releases/provention-bio-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-16-2023-301754445.html

PR NEWSWIRE
23 Feb 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty